January 26, 2024

Regenstrief research scientist named incoming president and CEO of AcademyHealth

Aaron Carroll, M.D.

Aaron Carroll, M.D., M.S., a research scientist in the Center for Health Services Research at Regenstrief Institute and the chief health officer at Indiana University, has been selected as the next president and chief executive officer (CEO) of AcademyHealth. Dr. Carroll will assume the role on March 18, 2024. 

Dr. Carroll will lead AcademyHealth into its next era of advocating for the use of evidence to improve the delivery of healthcare and to improve health for all. The AcademyHealth Board of Directors selected Dr. Carroll to bolster its work to improve health and health care for all by moving evidence into policy and practice. 

Chair of the AcademyHealth Board of Directors Lucy Savitz, PhD, MBA, states that the board was impressed with Dr. Carroll’s visible and impactful track record in translating complex research findings in a way to spark action as well as his passion for the development and mentoring of diverse research talent.  

Dr. Carroll additionally serves as the associate dean for research mentoring at IU School of Medicine and is a distinguished professor of pediatrics at IU. Dr. Carroll’s research focuses on the study of information technology to improve pediatric care, decision analysis and areas of health policy including cost-effectiveness of care and health care financing reform. 

As an expert science communicator, Dr. Carroll has authored multiple books, is a frequent contributor to the New York Times, a co-editor-in-chief of The Incidental Economist and his publications as well as his Healthcare Triage YouTube series and podcast have educated and entertained millions of readers and viewers.

AcademyHealth wrote about Dr. Carroll’s selection as their new president and CEO, read it here 

About Regenstrief Institute
Founded in 1969 in Indianapolis, the Regenstrief Institute is a local, national and global leader dedicated to a world where better information empowers people to end disease and realize true health. A key research partner to Indiana University, Regenstrief and its research scientists are responsible for a growing number of major healthcare innovations and studies. Examples range from the development of global health information technology standards that enable the use and interoperability of electronic health records to improving patient-physician communications, to creating models of care that inform clinical practice and improve the lives of patients around the globe. 

Sam Regenstrief, a nationally successful entrepreneur from Connersville, Indiana, founded the institute with the goal of making healthcare more efficient and accessible for everyone. His vision continues to guide the institute’s research mission. 

About AcademyHealth 
With nearly 3,000 individual and organizational members, AcademyHealth is the leading national organization serving the fields of health services and policy research and the professionals who produce and use this important work. Together with our members, we offer programs and services that support the development and use of rigorous, relevant and timely evidence to increase the quality, accessibility, and value of health care, to reduce disparities, and to improve health. A trusted broker of information, AcademyHealth brings stakeholders together to address the current and future needs of an evolving health system, inform health policy, and translate evidence into action. Learn more at 

Related News

screen captures from the Sickle Cell Data Dashboard

Bringing data to life: New interactive dashboard provides analysis and visualization of sickle cell disease prevalence and burden in an entire state

INDIANAPOLIS – The Indiana Sickle Cell Dashboard, launching this month on the Regenstrief Institute website, presents a dynamic, panoptic

Mental health stressors have differing impacts on odds of young adult use of nicotine or cannabis depending on race or ethnicity

Relationships of anxiety, depression, discrimination to substance use are dissimilar INDIANAPOLIS – Use of nicotine and cannabis products in